Sintilimab in Treating Advanced Lung Squamous Cell Carcinoma After Fourth-Line Treatment of Anlotinib Resistance
Am J Ther
.
2021 Jun 17.
doi: 10.1097/MJT.0000000000001386.
Online ahead of print.
Authors
Kai Wu
1
,
Li Wei
,
Yifan Fu
,
Daxiong Zeng
,
Changguo Wang
,
Junhong Jiang
Affiliation
1
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China Department of Pulmonary and Critical Care Medicine, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, China.
PMID:
34145167
DOI:
10.1097/MJT.0000000000001386
No abstract available